CAS RN: 133-89-1

Uridine 5′-(trihydrogen diphosphate), mono-alpha-d-glucopyranosyl ester

Product Availability

Choose a grade to view its available package options.

6 package records5 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20251111 25mg / 100mg / 500mg / 1g Confirm by inquiry Shanghai, Shandong, Guangdong, Chongqing, Hebei Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250114 100mg In stock Shanghai Inquiry
Batchno.20250920 1g In stock Shanghai Inquiry
Batchno.20250813 250mg In stock Shanghai Inquiry
Batchno.20260415 50mg In stock Shanghai Inquiry
Batchno.20251108 5g Out of stock Inquiry
  • Product code: starshine_CAS133-89-1
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

133-89-1 / [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

Standard CAS: 133-89-1 Multi CAS: No

Basic Information

CAS
133-89-1
Multi CAS
No
Molecular Formula
C15H24N2O17P2
Molecular Weight
566.300000
Exact Mass
566.055021
SMILES
C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O
InChI
InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8-,9-,10+,11-,12-,13-,14-/m1/s1
InChIKey
HSCJRCZFDFQWRP-JZMIEXBBSA-N

Physical Properties

Physical Description
Solid
State
Solid

Computed Properties

Structural Parameters

Heavy atom count
36
Aromatic heavy atom count
6
Fraction Csp3
0.73
Rotatable bonds
9
H-bond acceptors
16
H-bond donors
9
Molar refractivity
108.79
TPSA
296.99

LogP / Solubility

WLOGP
-4.79
MLOGP
-4.17
XLogP3
-6.3
Consensus LogP
-5.09
Log S (ESOL)
0.14
Class (ESOL)
Highly soluble
Log S (Ali)
-0.74
Class (Ali)
Very soluble
Log S (SILICOS-IT)
-0.44
Class (SILICOS-IT)
Very soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-9.58

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
9.5

Get In Touch

Contact Us